Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades

HIV Medicine

Volumn 11, Issue 9, 2010, Pages 593-602

  Lai, A ^a   Riva, C ^a   Marconi, A ^b   Balestrieri, M ^b   Razzolini, F ^b   Meini, G ^b   Vicenti, I ^b   Rosi, A ^b   Saladini, F ^b   Caramma, I ^a   Franzetti, M ^a   Rossini, V ^a   Galli, A ^a   Galli, M ^a   Violin, M ^a   Zazzi, M ^b   Balotta, C ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

HIV 1; New diagnoses of HIV 1 infection; Recombinants; Subtypes; Variability

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CLADISTICS; CONTROLLED STUDY; DEMOGRAPHY; ETHNICITY; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPECIES DIVERSITY; VIRUS STRAIN;

ADULT; CONTINENTAL POPULATION GROUPS; DEMOGRAPHY; EPIDEMIOLOGIC METHODS; FEMALE; GENES, POL; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; ITALY; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; SEX DISTRIBUTION; SEXUAL BEHAVIOR; TIME FACTORS;

EID: 77956450219     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2010.00832.x     Document Type: Article

References (37)

1. Robertson DL, Sharp PM, McCutchan FE, Hahn BH. Recombination in HIV-1. Nature 1995, 374:124-126.
2. Leitner T, Korber B, Daniels M, Calef C, Foley B. http://www.hiv.lanl.gov/content/sequence/HIV/COMPENDIUM/2005/partI/leitn er.pdf, HIV-1 Subtype and Circulating Recombinant Form (CRF) Reference Sequences, 2005. Los Alamos National Laboratory, Los Alamos, NM 87545., Available at, (accessed March 2010)
3. Taylor BS, Hammer SM. The challenge of HIV-1 subtype diversity. New Engl J Med 2008, 12:1590-1602.
4. Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006, 20:W13-W23.
5. Lukashov VV, Kuiken CL, Vlahov D, Coutinho RA, Goudsmit J. Evidence for HIV type 1 strains of U.S. intravenous drug users as founders of AIDS epidemic among intravenous drug users in northern Europe. AIDS Res Hum Retroviruses 1996, 12:1179-1183.
6. Sonnerborg A, Durdevic S, Giesecke J, Sällberg M. Dynamics of the HIV-1 subtype distribution in the Swedish HIV-1 epidemic during the period 1980 to 1993. AIDS Res Hum Retroviruses 1997, 13:343-345.
7. Balotta C, Facchi G, Violin M. ICONA study group. Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Defic Syndr 2001, 27:499-505.
8. Chaix ML, Descamps D, Harzic M. Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. AIDS 2003, 17:2635-2643.
9. Snoeck J, Van Laethem K, Hermans P. Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001. J Acquir Immune Defic Syndr 2004, 35:279-285.
10. Lospitao E, Alvarez A, Soriano V, Holguín A. HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003. HIV Med 2005, 6:313-320.
11. Gifford RJ, de Oliveira T, Rambaut A. Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1. J Virol 2007, 81:13050-13056.
12. Palma AC, Araújo F, Duque V, Borges F, Paixão MT, Camacho R. Portuguese SPREAD network. Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal. Infect Genet Evol 2007, 7:391-398.
13. Yerly S, von Wyl V, Ledergerber B. Swiss HIV cohort study. Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. AIDS 2007, 21:2223-2229.
14. Masquelier B, Bhaskaran K, Pillay D. CASCADE collaboration. Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003. J Acquir Immune Defic Syndr 2005, 40:505-511.
15. Wensing AM, Vijver DA, Angarano G. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J Infect Dis 2005, 192:958-966.
16. Wensing AMJ, Vercauteren J, Vijver DA. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. AIDS 2008, 22:625-635.
17. Thomson MM, Pérez-Alvarez L, Nájera R. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002, 2:461-471.
18. http://www.iss.it/binary/publ/cont/COAonline.pdf, Notiziario COA Marzo 2009. Available at, (accessed March 2010)
19. Lemey P, Derdelinckx I, Rambaut A. Molecular footprint of drug-selective pressure in a human immunodeficiency virus transmission chain. J Virol 2005, 79:11981-11989.
20. Hué S, Gifford RJ, Dunn D, Fernhill E, Pillay D. UK collaborative group on HIV drug resistance. Demonstration of sustained drug-resistant human immunodeficiency virus type 1 lineages circulating among treatment-naïve individuals. J Virol 2009, 83:2645-2654.
21. Zazzi M, Riccio ML, Venturi G. Long-read direct infrared sequencing of crude PCR products for prediction of resistance to HIV-1 reverse transcriptase and protease inhibitors. Mol Biotechnol 1998, 10:1-8.
22. Peduzzi C, Pierotti P, Venturi G. Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors. J Clin Virol 2002, 25:57-62.
23. Oelrichs RB, Workman C, Laukkanen T, McCutchan FE, Deacon NJ. A novel subtype A/G/J recombinant full-length HIV type 1 genome from Burkina Faso. AIDS Res Hum Retroviruses 1998, 14:1495-1500.
24. Nasioulas G, Paraskevis D, Magiorkinis E, Theodoridou M, Hatzakis A. Molecular analysis of the full-length genome of HIV type 1 subtype I: evidence of A/G/I recombination. AIDS Res Hum Retroviruses 1999, 15:745-758.
25. Monno L, Brindicci G, Lo Caputo S. HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy. J Med Virol 2005, 75:483-490.
26. Baldanti F, Paolucci S, Ravasi G. Changes in circulation of B and non-B HIV strains: spotlight on a reference centre for infectious diseases in Northern Italy. J Med Virol 2008, 80:947-952.
27. Thomson MM, Nájera R. Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. AIDS Rev 2005, 7:210-224.
28. Op De Coul E, van den Burg R, Asjö B. Genetic evidence of multiple transmissions of HIV type 1 subtype F within Romania from adult blood donors to children. AIDS Res Hum Retroviruses 2000, 16:327-336.
29. Thomson M, Sierra M, Tanuri A. Analysis of near full-length genome sequences of HIV type 1 BF intersubtype recombinant viruses from Brazil reveals their independent origins and their lack of relationship to CRF12_BF. AIDS Res Hum Retroviruses 2004, 20:1126-1133.
30. Razzolini F, Vicenti I, Saladini F. Natural variability in the HR-1 and HR-2 domains of HIV type 1 gp41 from different clades circulating in Italy. AIDS Res Hum Retroviruses 2007, 23:558-563.
31. Holguín A, López M, Molinero M, Soriano V. Performance of three commercial viral load assays, versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants. J Clin Microbiol 2008, 46:2918-2923.
32. Lobritz MA, Marozsan AJ, Troyer RM, Arts EJ. Natural variation in the V3 crown of human immunodeficiency virus type 1 affects replicative fitness and entry inhibitor sensitivity. J Virol 2007, 81:8258-8269.
33. Huang W, Eshleman SH, Toma J. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol 2007, 81:7885-7893.
34. Martinez-Cajas JL, Pai NP, Klein MB, Wainberg MA. Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008). J Int AIDS Soc 2009, 12:11.
35. Ariën KK, Abraha A, Quiñones-Mateu ME, Kestens L, Vanham G, Arts EJ. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J Virol 2005, 79:8979-8990.
36. Keller M, Lu Y, Lalonde RG, Klein MB. Impact of HIV-1 viral subtype on CD4+T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare. AIDS 2009, 23:731-737.
37. Eshleman SH, Guay LA, Mwatha A. Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV network for prevention trials 012. J Acquir Immune Defic Syndr 2005, 39:593-597.